Published in J Am Acad Dermatol on June 01, 1982
Platelet-derived factors enhance pemphigus acantholysis in skin organ cultures. Clin Exp Immunol (1986) 0.80
Serum levels of immune globulins in health and disease: a survey. Pediatrics (1966) 6.10
Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol (2000) 4.70
Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral load. JAMA (1996) 4.33
Severe candidal infections: clinical perspective, immune defense mechanisms, and current concepts of therapy. Ann Intern Med (1978) 4.15
Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team. N Engl J Med (1999) 4.12
Factors in the prognosis of meningococcal infection. Review of 63 cases with emphasis on recognition and management of the severely ill patient. J Pediatr (1966) 3.52
Rapid serologic testing with immune-complex-dissociated HIV p24 antigen for early detection of HIV infection in neonates. Southern California Pediatric AIDS Consortium. N Engl J Med (1993) 2.58
Elevated cord macroglobulins in the diagnosis of intrauterine infections. N Engl J Med (1966) 2.50
Passive immunity in prevention and treatment of infectious diseases. Clin Microbiol Rev (2000) 2.38
Bullous pemphigoid. Clinical and immunologic follow-up after successful therapy. Arch Dermatol (1977) 1.90
Deficiency of immune interferon production by leukocytes of normal newborns. Cell Immunol (1980) 1.85
Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus. J Am Acad Dermatol (2008) 1.81
Immunologic responses in malnourished children. Am J Clin Nutr (1975) 1.78
Decreased mononuclear and polymorphonuclear chemotaxis in human newborns, infants, and young children. Pediatrics (1977) 1.70
Increased prevalence of W27 in juvenile rheumatoid arthritis. N Engl J Med (1974) 1.58
Prevalence of autoimmune diseases in the family members of patients with pemphigus vulgaris. J Am Acad Dermatol (1994) 1.53
The Wiskott-Aldrich syndrome. Results of transfer factor therapy. J Clin Invest (1972) 1.50
Decreased rosette-forming lymphocytes in malnutrition and intrauterine growth retardation. J Pediatr (1974) 1.48
Decreased bactericidal activity of leukocytes of stressed newborn infants. Pediatrics (1975) 1.45
Standard and special human immune serum globulins as therapeutic agents. Pediatrics (1979) 1.44
Unrelated umbilical cord stem cell transplantation for X-linked immunodeficiencies. J Pediatr (2001) 1.41
Influence of intravenous immunoglobulin therapy on autoantibody titres to BP Ag1 and BP Ag2 in patients with bullous pemphigoid. J Eur Acad Dermatol Venereol (2003) 1.40
Impaired opsonic activity but normal phagocytosis in low-birth-weight infants. N Engl J Med (1969) 1.39
Clinical and immunologic features of dysgammaglobulinemia type I. Report of a case diagnosed in the first year of life. Am J Med (1966) 1.39
Early prognostic indicators in primary perinatal human immunodeficiency virus type 1 infection: importance of viral RNA and the timing of transmission on long-term outcome. J Infect Dis (1998) 1.37
Split products of fibrin in human renal disease. Am J Med (1969) 1.36
The syndrome of cellular immunodeficiency with immunoglobulins. J Pediatr (1974) 1.36
Elevated serum IgA globulin in anaphylactoid purpura. Pediatrics (1971) 1.35
Aspirin intolerance in chronic childhood asthma: Detected by oral challenge. Pediatrics (1975) 1.29
The natural history of disappearing bone tumours and tumour-like conditions. Clin Radiol (2001) 1.27
Defective T cell function in atopic dermatitis. J Allergy Clin Immunol (1976) 1.26
Structural basis for major histocompatibility complex (MHC)-linked susceptibility to autoimmunity: charged residues of a single MHC binding pocket confer selective presentation of self-peptides in pemphigus vulgaris. Proc Natl Acad Sci U S A (1995) 1.24
Interleukin-10: biology, role in inflammation and autoimmunity. Ann Allergy Asthma Immunol (1997) 1.23
Immune globulin levels in colostrum and breast milk, and serum from formula- and breast-fed newborns. Proc Soc Exp Biol Med (1967) 1.23
HLA-DRW4 in 91% of Jewish pemphigus vulgaris patients. Lancet (1979) 1.23
Coexistent respiratory allergy and cystic fibrosis. Am J Dis Child (1974) 1.21
Ventriculo-peritoneal shunt and breast carcinoma. Ann R Coll Surg Engl (2001) 1.20
Plasma infusions in immunologic deficiency states: metabolic and therapeutic studies. Blood (1966) 1.20
Correlation of peptide specificity and IgG subclass with pathogenic and nonpathogenic autoantibodies in pemphigus vulgaris: a model for autoimmunity. Proc Natl Acad Sci U S A (1995) 1.20
Use of intravenous gamma-globulin in antibody immunodeficiency: results of a multicenter controlled trial. Clin Immunol Immunopathol (1982) 1.14
Corticosteroids in treatment of obstructive lesions of chronic granulomatous disease. J Pediatr (1987) 1.14
Are desmoglein autoantibodies essential for the immunopathogenesis of pemphigus vulgaris, or just "witnesses of disease"? Exp Dermatol (2006) 1.13
Unusual subepidermal bullous diseases with immunologic features of bullous pemphigoid. Arch Dermatol (1979) 1.12
The DiGeorge syndrome and the fetal alcohol syndrome. Am J Dis Child (1982) 1.12
Intravenous immunoglobulin therapy for ocular cicatricial pemphigoid: a preliminary study. Ophthalmology (1999) 1.12
Pemphigus vegetans. Neumann type and Hallopeau type. Int J Dermatol (1984) 1.12
Rapid increases in load of human immunodeficiency virus correlate with early disease progression and loss of CD4 cells in vertically infected infants. J Infect Dis (1994) 1.10
UCLA conference. Interferon: immunobiology and clinical significance. Ann Intern Med (1982) 1.08
The chondro-osseous dysplasia of adenosine deaminase deficiency with severe combined immunodeficiency. J Pediatr (1976) 1.08
IgG antibody response to polyethylene glycol-modified adenosine deaminase in patients with adenosine deaminase deficiency. J Clin Invest (1992) 1.08
Fetal defense mechanisms. Am J Dis Child (1975) 1.07
Corticosteroids: a review with emphasis on complications of prolonged systemic therapy. Ann Allergy (1989) 1.06
Immune globulin levels in the sudden death syndrome. Pediatrics (1968) 1.06
T cell activation in pediatric AIDS pathogenesis: three-color immunophenotyping. Clin Immunol Immunopathol (1994) 1.05
Infectious complications of the primary immunodeficiencies. Clin Immunol Immunopathol (1986) 1.04
Demonstration of collagenase and elastase activities in the blister fluids from bullous skin diseases. Comparison between dermatitis herpetiformis and bullous pemphigoid. J Invest Dermatol (1983) 1.04
In vitro analysis of humoral immunity in antibody deficiency with normal immunoglobulins. Clin Immunol Immunopathol (1980) 1.03
Splenic hemangioma with thrombocytopenia and afibrinogenemia. J Pediatr (1968) 1.03
Influence of gestational age on serum levels of alpha-1 fetoprotein, IgG globulin, and albumin in newborn infants. J Pediatr (1973) 1.02
Esophagitis dissecans superficialis associated with pemphigus vulgaris. J Am Acad Dermatol (1981) 1.02
Miconazole in the treatment of chronic mucocutaneous candidiasis: a preliminary report. J Pediatr (1977) 1.02
Cellular (T cell) immunity in the human newborn. Pediatrics (1979) 1.01
Intravenous immunoglobulins as therapeutic agents. Ann Intern Med (1987) 1.01
The relationship of pemphigus to neoplasia. J Am Acad Dermatol (1990) 1.01
Pemphigoid gestationis: a review. Am J Obstet Gynecol (2000) 1.00
High dose intravenous immunoglobulin in atopic dermatitis and hyper-IgE syndrome. Ann Allergy Asthma Immunol (1998) 1.00
Differentiation between neonatal hepatitis and biliary atresia by measuring serum-alpha-fetoprotein. Lancet (1974) 0.99
Correlation of subclasses of IgG with disease activity in pemphigus vulgaris. Dermatology (1994) 0.99
Isolated absence of nasal cilia: a case report. Ann Allergy (1984) 0.99
Detection of pemphigus vulgaris antigen on COLO and SCaBER tumor cell lines by the immunoblot technique. Arch Dermatol Res (1990) 0.99
Decreased superoxide anion and hydrogen peroxide production by neutrophils and monocytes in human immunodeficiency virus-infected children and adults. Pediatr Res (1993) 0.98
Host defense in malnutrition. Pediatrics (1977) 0.97
Benefits and risks of intralesional corticosteroid injection in the treatment of dermatological diseases. Clin Exp Dermatol (1995) 0.96
Juvenile idiopathic polyarticular arthritis and IgA deficiency in the 22q11 deletion syndrome. J Rheumatol (2001) 0.96
Pigeon breeder's lung in children. Pediatrics (1967) 0.95
Complications according to mode of delivery among human immunodeficiency virus-infected women with CD4 lymphocyte counts of < or = 500/microL. Am J Obstet Gynecol (2000) 0.95
Identification of ocular cicatricial pemphigoid antibody binding site(s) in human beta4 integrin. Invest Ophthalmol Vis Sci (2001) 0.95
Activation and differentiation antigens on T cells of healthy, at-risk, and HIV-infected children. J Acquir Immune Defic Syndr (1993) 0.95
Intact humoral and cell-mediated immunity in chronic marijuana smoking. J Allergy Clin Immunol (1976) 0.94
HIV disease in children is associated with a selective decrease in CD23+ and CD62L+ B cells. Clin Immunol Immunopathol (1996) 0.93
Pemphigus vulgaris: the role of IL-1 and IL-1 receptor antagonist in pathogenesis and effects of intravenous immunoglobulin on their production. Clin Immunol (2001) 0.93
Influence of treatment on the clinical course of pemphigus vulgaris. J Am Acad Dermatol (1996) 0.93
Survival of oral human immune serum globulin in the gastrointestinal tract of low birth weight infants. Pediatr Res (1981) 0.93
Clinical and immunologic spectrum of the DiGeorge syndrome. J Clin Lab Immunol (1981) 0.93
Split products of fibrin in the serum of newborns. Pediatrics (1969) 0.93
Intravenous immunoglobulins in the therapy of autoimmune and systemic inflammatory disorders. Ann Allergy Asthma Immunol (1995) 0.93
Antibody-dependent lymphocyte killer function and age. Pediatrics (1973) 0.93
Cyclophosphamide (Cytoxan). A review on relevant pharmacology and clinical uses. J Am Acad Dermatol (1984) 0.93
Detection of pemphigus-like antigens on tumor cell lines. Arch Dermatol Res (1981) 0.92
Ocular cicatricial pemphigoid antigen: partial sequence and biochemical characterization. Proc Natl Acad Sci U S A (1996) 0.92
Antibody-dependent lymphocyte killer function in human immunodeficiency diseases. Clin Exp Immunol (1975) 0.92
Identical MHC markers in non-Jewish Iranian and Ashkenazi Jewish patients with pemphigus vulgaris: possible common central Asian ancestral origin. Hum Immunol (1997) 0.92
Novel splicing, missense, and deletion mutations in seven adenosine deaminase-deficient patients with late/delayed onset of combined immunodeficiency disease. Contribution of genotype to phenotype. J Clin Invest (1993) 0.92